A. Daniel

Studies concerning the cardiovascular actions of the central nervous stimulant, methylphenidate.

R. Maxwell, A. Plummer, S. D. Ross, 1958, The Journal of pharmacology and experimental therapeutics.

Pharmacology of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (Su-5864).

F. Schneider, R. Maxwell, A. Plummer, 1960, The Journal of pharmacology and experimental therapeutics.

Some interactions of guanethidine, cocaine, methylphenidate and phenylalkylamines in rabbit aortic strips.

R. Maxwell, H. Sheppard, A. Daniel, 1962, Journal of Pharmacology and Experimental Therapeutics.

Concerning the mechanisms of the cardiovascular actions of hexahydro-1-azepinepropionamidoxime (SU-4029).

F. Schneider, R. Maxwell, A. Plummer, 1958, The Journal of pharmacology and experimental therapeutics.

Some actions of methylphenidate on the vascular system, arterial tissue and the nictitating membrane.

R. Holland, F. Schneider, R. Maxwell, 1961, The Journal of pharmacology and experimental therapeutics.

Does histamine influence vasodilation caused by prolonged arterial occlusion or heavy exercise?

A. Daniel, C. R. Honig, 1980, Journal of Pharmacology and Experimental Therapeutics.